Resultado de búsqueda
Research Resources Available Through The Michael J. Fox Foundation. MJFF is committed to providing support and resources to those invested in Parkinson’s research— across academia, ... in peer-reviewed scientific publications and with white paper reports. View Publications Questions?
11 de oct. de 2022 · La lección de Michael J. Fox sobre el párkinson: qué ocurre cuando te lo diagnostican con 29 años. Un 10% de los diagnosticados con este trastorno lo desarrollan de forma juvenil. En ellos, la ...
Michael J. Fox in 2012. Michael J. Fox, artiestennaam van Michael Andrew Fox, (Edmonton, Alberta, 9 juni 1961) is een van geboorte Canadees acteur, die voornamelijk bekend is geworden door zijn rol als Alex P. Keaton in Family Ties en als Marty McFly in de Back to the Future-trilogie.Ook speelde hij Mike Flaherty in de televisieserie Spin City.. Fox gebruikt als tweede initiaal de 'J.', als ...
Michael Andrew Fox, conegut com a Michael J. Fox OC (Edmonton, Alberta, 9 de juny de 1961) és un actor, autor, productor i activista amb doble nacionalitat canadenca i estatunidenca. Va iniciar la seva carrera d'actor el 1973 i un dels seus papers més recordats al cinema és el de Marty McFly a la trilogia Back to the Future (1985–1990).. Se li va diagnosticar molt prematurament la ...
Research Resources. The Michael J. Fox Foundation believes strongly in the value of open science, which is why we have assembled all of our tools and resources in one place. Join us in our efforts to cure Parkinson's disease. Funding Opportunities. MJFF offers new funding opportunities every quarter to researchers, clinicians and industry partners.
Our Partners. The Michael J. Fox Foundation and the world's leading consumer genetics company 23andMe have partnered to assemble a more complete picture of Parkinson's by integrating genetic and patient-reported data. 23andMe's mission is to help people access, understand and benefit from the human genome.
30 de abr. de 2023 · 3 min. In a revealing interview, the actor Michael J. Fox spoke about his own mortality and the challenges of living with Parkinson’s disease for more than 30 years, including his experiences ...
